215 related articles for article (PubMed ID: 12127201)
21. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.
Haney M; Gunderson EW; Rabkin J; Hart CL; Vosburg SK; Comer SD; Foltin RW
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):545-54. PubMed ID: 17589370
[TBL] [Abstract][Full Text] [Related]
22. Effects of delta 9-tetrahydrocannabinol and social context on marijuana self-administration by humans.
Kelly TH; Foltin RW; Mayr MT; Fischman MW
Pharmacol Biochem Behav; 1994 Nov; 49(3):763-8. PubMed ID: 7862735
[TBL] [Abstract][Full Text] [Related]
23. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
24. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
Haney M; Rabkin J; Gunderson E; Foltin RW
Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
[TBL] [Abstract][Full Text] [Related]
25. Marijuana's dose-dependent effects in daily marijuana smokers.
Ramesh D; Haney M; Cooper ZD
Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
[TBL] [Abstract][Full Text] [Related]
26. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
Heishman SJ; Stitzer ML; Yingling JE
Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
[TBL] [Abstract][Full Text] [Related]
27. Methamphetamine self-administration by humans.
Hart CL; Ward AS; Haney M; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 Aug; 157(1):75-81. PubMed ID: 11512046
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in the subjective effects of oral Δ
Fogel JS; Kelly TH; Westgate PM; Lile JA
Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
[TBL] [Abstract][Full Text] [Related]
30. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
[TBL] [Abstract][Full Text] [Related]
31. Effects of smoked marijuana in healthy and HIV + marijuana smokers.
Haney M
J Clin Pharmacol; 2002 Nov; 42(S1):34S-40S. PubMed ID: 12412834
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.
Bedi G; Foltin RW; Gunderson EW; Rabkin J; Hart CL; Comer SD; Vosburg SK; Haney M
Psychopharmacology (Berl); 2010 Dec; 212(4):675-86. PubMed ID: 20824270
[TBL] [Abstract][Full Text] [Related]
33. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
[TBL] [Abstract][Full Text] [Related]
34. Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.
Keith DR; Gunderson EW; Haney M; Foltin RW; Hart CL
Drug Alcohol Depend; 2017 Sep; 178():534-543. PubMed ID: 28728115
[TBL] [Abstract][Full Text] [Related]
35. Delta-9-tetrahydrocannabinol content and human marijuana self-administration.
Chait LD
Psychopharmacology (Berl); 1989; 98(1):51-5. PubMed ID: 2543018
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
Cooper ZD; Comer SD; Haney M
Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
[TBL] [Abstract][Full Text] [Related]
37. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
JAMA Netw Open; 2018 Nov; 1(7):e184841. PubMed ID: 30646391
[TBL] [Abstract][Full Text] [Related]
38. The pharmacologic effects of daily marijuana smoking in humans.
Perez-Reyes M; White WR; McDonald SA; Hicks RE; Jeffcoat AR; Cook CE
Pharmacol Biochem Behav; 1991 Nov; 40(3):691-4. PubMed ID: 1666929
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
Wachtel SR; de Wit H
Drug Alcohol Depend; 2000 Jun; 59(3):251-60. PubMed ID: 10812285
[TBL] [Abstract][Full Text] [Related]
40. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
